Bausch Health Companies Inc.
$22.19B- Market cap
- $2.45B
- Debt
- +$21.04B
- Cash
- −$1.31B
Capital structure 10% equity / 90% debt · EV / Revenue 2.16x · EV / EBITDA 9.16x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: BHC stock price near parity vs UMBF $6.56 current versus $6.50 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at UMBF's multiple
Implied fair value · at BHC's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple premium
Expensive
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: BHC FY 2025 (ended Dec 31, 2025) · UMBF FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 10% equity / 90% debt · EV / Revenue 2.16x · EV / EBITDA 9.16x
Capital structure 96% equity / 4% debt · EV / Revenue 1.08x · EV / EBITDA 1.49x
BHC carries the larger enterprise value at $22.19B against $3.62B; UMBF trades on the lower EV / Revenue multiple (1.08x vs 2.16x); UMBF on the lower EV / EBITDA (1.49x vs 9.16x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Bausch Health Companies Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
UMB FINANCIAL CORP · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
-37.98x
0.06x
Net debt / EBITDA
Leverage against operating earnings
8.15x
-3.00x
Cash and equivalents
Liquid reserves on the balance sheet
$1.31B
$7.77B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
AbbVie Inc.
BHC vs ABBV
Organon & Co.
BHC vs OGN
TEVA PHARMACEUTICAL INDUSTRIES LTD
BHC vs TEVA
SUPERNUS PHARMACEUTICALS, INC.
BHC vs SUPN
ANI PHARMACEUTICALS INC
BHC vs ANIP
FIFTH THIRD BANCORP
BHC vs FITB
REGIONS FINANCIAL CORP
BHC vs RF
KEYCORP /NEW/
BHC vs KEY
HANCOCK WHITNEY CORP
BHC vs HWC
OLD NATIONAL BANCORP /IN/
BHC vs ONB
$21.04B
$474.23M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.